UC Tweets Stand Out in Global Pharmacist Tweet-A-Thon
First-year PharmD student Nikita Nambiar has tweeted almost 7,000 times since she opened her Twitter account in 2011, so she was pretty primed to help UCs James L. Winkle College of Pharmacy rock the Global Pharmacist Tweet-A-Thon on October 2
and she did.
Using the required hashtag (#Pharmacist), Nambiar tweeted a photo of M&Ms in a prescription bottle that she is required to take as part of the colleges skills lab course so she can better understand the challenges in taking "medication. By 5 p.m., her tweet had made the "Pharmacy Times list of the most popular worldwide out of 8,000 tweets.
Dean Neil MacKinnon, PhD, who is quite the Twitter user himself, ranked 7th in the top 10 "#pharmacist mentions globally by the end of the day.
"The event is a great way to connect with pharmacists from across the globe. Many of our students, faculty and alumni participated in the event and it was great to see their tweets about our college and the profession retweeted by pharmacists in Ireland, Australia and in other locations worldwide.
This was the second year for the Pharmacist Tweet-A-Thon, the first of which generated 7,000 tweets Oct. 3, 2013. Many American and international pharmacy organizations participated in the event.
Tags
Related Stories
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.
Certain weather patterns can trigger migraines
June 8, 2026
Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.